Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$4.27 USD
+0.04 (0.95%)
Updated Aug 8, 2025 03:58 PM ET
After-Market: $4.24 -0.03 (-0.70%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APDN 4.27 +0.04(0.95%)
Will APDN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APDN
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Intellicheck Mobilisa, Inc. (IDN) Reports Q3 Loss, Misses Revenue Estimates
GrafTech International (EAF) Reports Q3 Loss, Tops Revenue Estimates
Resideo Technologies (REZI) Q3 Earnings and Revenues Top Estimates
Other News for APDN
Applied DNA Sciences (APDN) Secures Significant Follow-On Order | APDN Stock News
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in ...
Applied DNA Sciences announces new follow-on LineaDNA order
Applied DNA Sciences regains Nasdaq compliance
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements | APDN Stock News